Capricor's biologics license application for deramiocel (CAP-1002) is draws largely on the Phase 2 HOPE-2 trial and its ...
Muscular Dystrophy News Today covered the latest studies, treatment advances, and clinical trials for different types of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback